PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Choline Alfoscerate→

Choline Alfoscerate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
28319-77-9
Molecular formula
C8H20NO6P
Molecular weight
257.22 g/mol
Drug class
Cholinergic compoundacetylcholine precursor and glycerophospholipid intermediate
Mechanism of action
L-alpha-glycerylphosphorylcholine (alpha-GPC) supplies choline for acetylcholine synthesis and is a phospholipid-related metabolite. Proposed central nervous system effects relate to choline availability and membrane phospholipid metabolism; a reliable disease-modifying mechanism has not been established.
Indications / reported uses
  • Marketed in some countries for cognitive symptoms or as a choline-containing supplement, but clinical efficacy evidence and authorised indications vary. It should not be assigned a universal approved indication.

Sources: https://pubchem.ncbi.nlm.nih.gov/compound/alpha-glycerylphosphorylcholine · https://www.ncbi.nlm.nih.gov/mesh/68005997 · https://pmc.ncbi.nlm.nih.gov/articles/PMC13200208/ · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Choline Alfoscerate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Choline Alfoscerate Permitted Daily Exposure (PDE) report (the Choline Alfoscerate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Choline Alfoscerate Occupational Exposure Limit (OEL) report (the Choline Alfoscerate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.